| The Bristol & Avon Dermatology Research Trust Limited |
| Registered number: |
04334810 |
| Balance Sheet |
| as at 31 March 2026 |
|
| Notes |
|
|
2026 |
|
|
2025 |
| £ |
£ |
| Current assets |
| Cash at bank and in hand |
|
|
86,762 |
|
|
92,726 |
|
| Creditors: amounts falling due within one year |
3 |
|
(322) |
|
|
44 |
|
| Net current assets |
|
|
|
86,440 |
|
|
92,770 |
|
| Total assets less current liabilities |
|
|
|
86,440 |
|
|
92,770 |
|
| Creditors: amounts falling due after more than one year |
4 |
|
|
(200) |
|
|
(200) |
|
|
|
| Net assets |
|
|
|
86,240 |
|
|
92,570 |
|
|
|
|
|
|
|
|
| Capital and reserves |
| Profit and loss account |
|
|
|
86,240 |
|
|
92,570 |
|
| Shareholders' funds |
|
|
|
86,240 |
|
|
92,570 |
|
|
|
|
|
|
|
|
| The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006. |
| The members have not required the company to obtain an audit in accordance with section 476 of the Act. |
| The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. |
| The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies. |
|
|
|
|
| Janet Angus |
| Director |
| Approved by the board on 21 October 2026 |
|
| The Bristol & Avon Dermatology Research Trust Limited |
| Notes to the Accounts |
| for the year ended 31 March 2026 |
|
|
| 1 |
Accounting policies |
|
|
Basis of preparation |
|
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard). |
|
|
Debtors |
|
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts. |
|
|
Creditors |
|
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method. |
|
|
| 2 |
Employees |
2026 |
|
2025 |
| Number |
Number |
|
|
Average number of persons employed by the company |
- |
|
- |
|
|
|
|
|
|
|
|
|
|
| 3 |
Creditors: amounts falling due within one year |
2026 |
|
2025 |
| £ |
£ |
|
|
Other creditors |
322 |
|
(44) |
|
|
|
|
|
|
|
|
|
|
| 4 |
Creditors: amounts falling due after one year |
2026 |
|
2025 |
| £ |
£ |
|
|
Other creditors |
200 |
|
200 |
|
|
|
|
|
|
|
|
|
|
| 5 |
Other information |
|
|
The Bristol & Avon Dermatology Research Trust Limited is a private company limited by shares and incorporated in England. Its registered office is: |
|
Bristol Royal Infirmary |
|
Marlborough Street, |
|
Bristol |
|
England |
|
BS2 8HW |